M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.89 USD -1.35% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

Wall Street
Price Targets

MLTX Price Targets Summary
MoonLake Immunotherapeutics

Wall Street analysts forecast MLTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLTX is 74.31 USD with a low forecast of 40.4 USD and a high forecast of 109.2 USD.

Lowest
Price Target
40.4 USD
22% Downside
Average
Price Target
74.31 USD
43% Upside
Highest
Price Target
109.2 USD
110% Upside

MLTX Last Price Targets
MoonLake Immunotherapeutics

The latest public price target was made on Jul 1, 2024 by Raghuram Selvaraju from H.C. Wainwright , who expects MLTX stock to rise by 93% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Raghuram Selvaraju
H.C. Wainwright
100 USD
Upside 93%
4 months ago
Jul 1, 2024
H.C. Wainwright Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
StreetInsider
Richard Law
Goldman Sachs
62 USD
Upside 19%
7 months ago
Apr 2, 2024
Goldman Sachs Starts Moonlake Immunotherapeutics (MLTX ) at Neutral, 'Competing Against Large Pharma Companies Is No Easy Task'
StreetInsider
Serge Belanger
Needham
76 USD
Upside 46%
1 year ago
Aug 31, 2023
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
Benzinga
Raghuram Selvaraju
H.C. Wainwright
28 USD
Downside 46%
2 years ago
Jul 22, 2022
MoonLake Immunotherapeutics (MLTX) Stock: Why It Increased 4.63% Today
Pulse 2.0
Raghuram Selvaraju
H.C. Wainwright
Price Target 100 USD
Upside/Downside 93%
View Source
Richard Law
Goldman Sachs
Price Target 62 USD
Upside/Downside 19%
View Source
Serge Belanger
Needham
Price Target 76 USD
Upside/Downside 46%
View Source
Raghuram Selvaraju
H.C. Wainwright
Price Target 28 USD
Upside/Downside 46%
View Source
MoonLake Immunotherapeutics Competitors:
Price Targets
SYNGENE
Syngene International Ltd
13% Downside
1167
Jacobio Pharmaceuticals Group Co Ltd
114% Upside
AMGN
Amgen Inc
14% Upside
ALVO
Alvotech SA
59% Upside
ITCI
Intra-Cellular Therapies Inc
11% Upside
LQDA
Liquidia Corp
143% Upside
AVTE
Aerovate Therapeutics Inc
11% Downside
ACLX
Arcellx Inc
7% Downside

Revenue
Forecast

Revenue Estimate
MoonLake Immunotherapeutics

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
MoonLake Immunotherapeutics

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
MoonLake Immunotherapeutics

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MLTX's stock price target?
Price Target
74.31 USD

According to Wall Street analysts, the average 1-year price target for MLTX is 74.31 USD with a low forecast of 40.4 USD and a high forecast of 109.2 USD.

Back to Top